Skip to main content

Advertisement

SpringerLink
Log in

Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD)

  • Review
  • Published:
Cell and Tissue Research Aims and scope Submit manuscript

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) belongs to a group of congenital hepatorenal fibrocystic syndromes characterized by dual renal and hepatic involvement of variable severity. Despite the wide clinical spectrum of ARPKD (MIM 263200), genetic linkage studies indicate that mutations at a single locus, PKHD1 (polycystic kidney and hepatic disease 1), located on human chromosome region 6p21.1–p12, are responsible for all phenotypes of ARPKD. Identification of cystic disease genes and their encoded proteins has provided investigators with critical tools to begin to unravel the molecular and cellular mechanisms of PKD. PKD cystic epithelia share common phenotypic abnormalities despite the different genetic mutations that underlie the disease. Recent studies have shown that many cyst-causing proteins are expressed in multimeric complexes at distinct subcellular locations within epithelia. This co-expression of cystoproteins suggests that cyst formation, regardless of the underlying disease gene, results from perturbations in convergent and/or integrated signal transduction pathways. To date, no specific therapies are in clinical use for ameliorating cyst growth in ARPKD. However, studies noted in this review suggest that therapeutic targeting of the cAMP and epidermal growth factor receptor (EGFR)-axis abnormalities in cystic epithelia may translate into effective therapies for ARPKD and, by analogy, autosomal dominant polycystic kidney disease (ADPKD). A particularly promising approach appears to be the targeting of downstream intermediates of both the cAMP and EGFR axis. This review focuses on ARPKD and presents a concise summary of the current understanding of the molecular genetics and cellular pathophysiology of this disease. It also highlights phenotypic and mechanistic similarities between ARPKD and ADPKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Adeva M, El-Youssef M, Rosetti S, Kamath PS, Kubly V, Consugar MB, Milliner DM, King BF, Torres VE, Harris PC (2006) Clinical and molecular characterizations defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine 85:1–21

    PubMed  Google Scholar 

  • Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp GM Jr, Grantham JJ (2004) Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 66:964–973

    PubMed  CAS  Google Scholar 

  • Bergmann C, Senderek J, Sedlacek B, Pegiazoglou I, Puglia P, Eggermann T, Rudnik-Schoneborn S, Furu L, Onuchic LF, De Baca M, Germino GG, Guay-Woodford L, Somlo S, Moser M, Buttner R, Zerres K (2003) Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J Am Soc Nephrol 14:76–89

    PubMed  CAS  Google Scholar 

  • Bergmann C, Senderek J, Kupper F, Schneider F, Dornia C, Windelen E, Eggermann T, Rudnik-Schoneborn S, Kirfel J, Furu L, Onuchic LF, Rossetti S, Harris PC, Somlo S, Guay-Woodford L, Germino GG, Moser M, Buttner R, Zerres K (2004a) PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat 23:453–463

    PubMed  CAS  Google Scholar 

  • Bergmann C, Senderek J, Schneider F, Dornia C, Kupper F, Eggermann T, Rudnik-Schoneborn S, Kirfel J, Moser M, Buttner R, Zerres K (2004b) PKHD1 mutations in families requesting prenatal diagnosis for autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat 23:487–495

    PubMed  CAS  Google Scholar 

  • Bergmann C, Kupper F, Dornia C, Schneider F, Senderek J, Zerres K (2005a) Algorithm for efficient PKHD1 mutation screening in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat 25:225–231

    PubMed  CAS  Google Scholar 

  • Bergmann C, Kupper F, Schmitt CP, Vester U, Neuhaus TJ, Senderek J, Zerres K (2005b) Multi-exon deletions of the PKHD1 gene cause autosomal recessive polycystic kidney disease (ARPKD). J Med Genet 42:e63

    PubMed  CAS  Google Scholar 

  • Bergmann C, Senderek J, Windelen E, Kupper F, Middeldorf I, Schneider F, Dornia C, Rudnik-Schoneborn S, Konrad M, Schmitt CP, Seeman T, Neuhaus TJ, Vester U, Kirfel J, Buttner R, Zerres K (2005c) Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int 67:829–848

    PubMed  CAS  Google Scholar 

  • Bernstein J, Slovis TL (1992) Polycystic diseases of the kidney. In: Edelmann C (ed) Pediatric kidney diseases. Little, Brown, Boston, pp 1139–1157

    Google Scholar 

  • Blyth H, Ockenden BG (1971) Polycystic disease of kidneys and liver presenting in childhood. J Med Genet 8:257–284

    Article  PubMed  CAS  Google Scholar 

  • Boschelli DH, Wu B, Barrios Sosa AC, Chen JJ, Golas JM, Boschelli F (2005a) Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles. Bioorg Med Chem Lett 15:4681–4684

    PubMed  CAS  Google Scholar 

  • Boschelli DH, Wu B, Barrios Sosa AC, Durutlic H, Chen JJ, Wang Y, Golas JM, Lucas J, Boschelli F (2005b) Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles. J Med Chem 48:3891–3902

    PubMed  CAS  Google Scholar 

  • Clarke LL, Grubb BR, Gabriel SE, Smithies O, Koller BH, Boucher RC (1992) Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science 257:1125–1128

    PubMed  CAS  Google Scholar 

  • Cole BR, Conley SB, Stapleton FB (1987) Polycystic kidney disease in the first year of life. J Pediatr 111:693–699

    PubMed  CAS  Google Scholar 

  • Davis ID, MacRae Dell K, Sweeney WE, Avner ED (2001) Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented? Semin Nephrol 21:430–440

    PubMed  CAS  Google Scholar 

  • Davis ID, Ho M, Hupertz V, Avner ED (2003) Survival of childhood polycystic kidney disease following renal transplantation: the impact of advanced hepatobiliary disease. Pediatr Transplant 7:364–369

    PubMed  Google Scholar 

  • Dell K, Avner E (2003) Autosomal recessive polycystic kidney disease gene reviews; genetic disease online reviews at gene tests-gene clinics. University of Washington, Seattle

    Google Scholar 

  • Dell KM, Nemo R, Sweeney WE, Levin JI, Frost P, Avner ED (2001) A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease. Kidney Int 60:1240–1248

    PubMed  CAS  Google Scholar 

  • Dell K, McDonald R, Watkins SL, Avner ED (2004) Polycystic kidney disease. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology. Lippincott Williams & Wilkins, Philadelphia, pp 675–699

    Google Scholar 

  • Desmet VJ (1992) Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation”. Hepatology 16:1069–1083

    PubMed  CAS  Google Scholar 

  • Du J, Wilson PD (1995) Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 269:C487–C495

    PubMed  CAS  Google Scholar 

  • Furu L, Onuchic LF, Gharavi A, Hou X, Esquivel EL, Nagasawa Y, Bergmann C, Senderek J, Avner E, Zerres K, Germino GG, Guay-Woodford LM, Somlo S (2003) Milder presentation of recessive polycystic kidney disease requires presence of amino acid substitution mutations. J Am Soc Nephrol 14:2004–2014

    PubMed  CAS  Google Scholar 

  • Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329:332–342

    PubMed  CAS  Google Scholar 

  • Gattone VH 2nd, Kuenstler KA, Lindemann GW, Lu X, Cowley BD Jr, Rankin CA, Calvet JP (1996) Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse. J Lab Clin Med 127:214–222

    PubMed  CAS  Google Scholar 

  • Gattone VH 2nd, Wang X, Harris PC, Torres VE (2003) Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9:1323–1326

    PubMed  CAS  Google Scholar 

  • Grantham JJ (1996) The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. Am J Kidney Dis 28:788–803

    PubMed  CAS  Google Scholar 

  • Grantham JJ (1997a) Mechanisms of progression in autosomal dominant polycystic kidney disease. Kidney Int Suppl 63:S93–S97

    PubMed  CAS  Google Scholar 

  • Grantham JJ (1997b) Renal cell proliferation and the two faces of cyclic adenosine monophosphate. J Lab Clin Med 130:460–469

    Google Scholar 

  • Grantham JJ (2000) Time to treat polycystic kidney diseases like the neoplastic disorders that they are. Kidney Int 57:339–340

    PubMed  CAS  Google Scholar 

  • Grantham JJ, Geiser JL, Evan AP (1987) Cyst formation and growth in autosomal dominant polcystic kidney disease. Kidney Int 31:1145–1152

    PubMed  CAS  Google Scholar 

  • Grantham JJ, Ye M, Davidow C, Holub B, Sharma M (1995) Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6:1242–1249

    PubMed  CAS  Google Scholar 

  • Guan KL, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD, Vojtek AB (2000) Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem 275:27354–27359

    PubMed  CAS  Google Scholar 

  • Guay-Woodford L (1996) Autosomal recessive polycystic kidney disease. In: Watson M, Torres VH (eds) Polycystic kidney disease. Oxford University Press, New York

    Google Scholar 

  • Guay-Woodford LM (2003) Murine models of polycystic kidney disease: molecular and therapeutic insights. Am J Physiol Renal Physiol 285:F1034–F1049

    PubMed  CAS  Google Scholar 

  • Guay-Woodford LM, Desmond RA (2003) Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 111:1072–1080

    PubMed  Google Scholar 

  • Guay-Woodford LM, Muecher G, Hopkins SD, Avner ED, Germino GG, Guillot AP, Herrin J, Holleman R, Irons DA, Primack W, Thomson PD, Waldo FB, Lunt PW, Zerres K (1995) The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1–p12: implications for genetic counseling. Am J Hum Genet 56:1101–1107

    PubMed  CAS  Google Scholar 

  • Gunay-Aygun M, Avner ED, Bacallao RL, et al (2006) Autosomal recessive polycystic kidney disease NIH symposium summary statement. J Pediatr (in press)

  • Harris PC, Rossetti S (2004) Molecular genetics of autosomal recessive polycystic kidney disease. Mol Genet Metab 81:75–85

    PubMed  CAS  Google Scholar 

  • Hiesberger T, Bai Y, Shao X, McNally BT, Sinclair AM, Tian X, Somlo S, Igarashi P (2004) Mutation of hepatocyte nuclear factor-1{beta} inhibits Pkhd1 gene expression and produces renal cysts in mice. J Clin Invest 113:814–825

    PubMed  CAS  Google Scholar 

  • Hildebrandt F, Otto E (2005) Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease? Nat Rev Genet 6:928–940

    Article  PubMed  CAS  Google Scholar 

  • Hogan MC, Griffin MD, Rossetti S, Torres VE, Ward CJ, Harris PC (2003) PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression. Hum Mol Genet 12:685–698

    PubMed  CAS  Google Scholar 

  • Igarashi P, Somlo S (2002) Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 13:2384–2398

    PubMed  CAS  Google Scholar 

  • Igarashi P, Shao X, McNally BT, Hiesberger T (2005) Roles of HNF-1beta in kidney development and congenital cystic diseases. Kidney Int 68:1944–1947

    PubMed  CAS  Google Scholar 

  • Jafar TH, Stark PC, Schmid CH, Strandgaard S, Kamper AL, Maschio G, Becker G, Perrone RD, Levey AS (2005) The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int 67:265–271

    PubMed  CAS  Google Scholar 

  • Jiang ST, Chiou YY, Wang E, Lin HK, Lin YT, Chi YC, Wang CK, Tang MJ, Li H (2006) Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of pkd1. Am J Pathol 168:205–220

    PubMed  CAS  Google Scholar 

  • Jorgensen MJ (1977) The ductal plate malformation. Acta Pathol Microbiol Scand Suppl 257:1–87

    PubMed  Google Scholar 

  • Kaariainen H, Koskimies O, Norio R (1988) Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data. Pediatr Nephrol 2:296–302

    PubMed  CAS  Google Scholar 

  • Kaplan BS, Fay J, Shah V, Dillon MJ, Barratt TM (1989) Autosomal recessive polycystic kidney disease. Pediatr Nephrol 3:43–49

    PubMed  CAS  Google Scholar 

  • Klingel R, Dippold W, Storkel S, Meyer zum Buschenfelde KH, Kohler H (1992) Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma. Am J Kidney Dis 19:22–30

    PubMed  CAS  Google Scholar 

  • Lakshmanan J, Fisher DA (1993) An inborn error in epidermal growth factor prohormone metabolism in a mouse model of autosomal recessive polycystic kidney disease. Biochem Biophys Res Commun 196:892–901

    PubMed  CAS  Google Scholar 

  • Lin F, Hiesberger T, Cordes K, Sinclair AM, Goldstein LS, Somlo S, Igarashi P (2003) Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc Natl Acad Sci USA 100:5286–5291

    PubMed  CAS  Google Scholar 

  • Losekoot M, Haarloo C, Ruivenkamp C, White SJ, Breuning MH, Peters DJ (2005) Analysis of missense variants in the PKHD1-gene in patients with autosomal recessive polycystic kidney disease (ARPKD). Hum Genet 118:185–206

    PubMed  CAS  Google Scholar 

  • Lowden DA, Lindemann GW, Merlino G, Barash BD, Calvet JP, Gattone VH 2nd (1994) Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med 124:386–394

    PubMed  CAS  Google Scholar 

  • Lu W, Fan X, Babakhanlou H, Law T, Rifal N, Harris PC, Perez-Atayde AR, Renneke HG, Zhou J (1999) Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Gen 21:160–161

    CAS  Google Scholar 

  • MacRae Dell K, Nemo R, Sweeney WE Jr, Avner ED (2004) EGF-related growth factors in the pathogenesis of murine ARPKD. Kidney Int 65:2018–2029

    PubMed  Google Scholar 

  • Masyuk TV, Huang BQ, Ward CJ, Masyuk AI, Yuan D, Splinter PL, Punyashthiti R, Ritman EL, Torres VE, Harris PC, LaRusso NF (2003) Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology 125:1303–1310

    PubMed  CAS  Google Scholar 

  • Menezes LF, Cai Y, Nagasawa Y, Silva AM, Watkins ML, Da Silva AM, Somlo S, Guay-Woodford LM, Germino GG, Onuchic LF (2004) Polyductin, the PKHD1 gene product, comprises isoforms expressed in plasma membrane, primary cilium, and cytoplasm. Kidney Int 66:1345–1355

    PubMed  CAS  Google Scholar 

  • Murcia NS, Sweeney WE, Avner ED (1999) New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 55:1187–1197

    PubMed  CAS  Google Scholar 

  • Nagano J, Kitamura K, Hujer KM, Ward CJ, Bram RJ, Hopfer U, Tomita K, Huang C, Miller RT (2005) Fibrocystin interacts with CAML, a protein involved in Ca(2+) signaling. Biochem Biophys Res Commun 338:880–889

    PubMed  CAS  Google Scholar 

  • Nagasawa Y, Matthiesen S, Onuchic LF, Hou X, Bergmann C, Esquivel E, Senderek J, Ren Z, Zeltner R, Furu L, Avner E, Moser M, Somlo S, Guay-Woodford L, Buttner R, Zerres K, Germino GG (2002) Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene. J Am Soc Nephrol 13:2246–2258

    PubMed  CAS  Google Scholar 

  • Nakanishi K, Sweeney WE Jr, Macrae Dell K, Cotton CU, Avner ED (2001) Role of CFTR in autosomal recessive polycystic kidney disease. J Am Soc Nephrol 12:719–725

    PubMed  CAS  Google Scholar 

  • Nauli SM, Zhou J (2004) Polycystins and mechanosensation in renal and nodal cilia. Bioessays 26:844–856

    PubMed  CAS  Google Scholar 

  • Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J (2003) Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33:129–137

    PubMed  CAS  Google Scholar 

  • Nauta J, Sweeney WE, Rutledge JC, Avner ED (1995) Biliary epithelial cells from mice with congenital polycystic kidney disease are hyperresponsive to epidermal growth factor. Pediatr Res 37:755–763

    PubMed  CAS  Google Scholar 

  • Neufield TK, Douglass D, Grant M, Ye M, Silva F, Nadasdy T, Grantham JJ (1992) In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. Kidney Int 41:1222–1236

    Google Scholar 

  • Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C, Senderek J, Esquivel E, Zeltner R, Rudnik-Schoneborn S, Mrug M, Sweeney W, Avner ED, Zerres K, Guay-Woodford LM, Somlo S, Germino GG (2002) PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 70:1305–1317

    PubMed  CAS  Google Scholar 

  • Orellana SA, Sweeney WE, Neff CD, Avner ED (1995) Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int 47:490–499

    PubMed  CAS  Google Scholar 

  • Osathanondh V, Potter EL (1964a) Pathogenesis of polycystic kidneys. Historical survey. Arch Pathol 77:459–465

    PubMed  CAS  Google Scholar 

  • Osathanondh V, Potter EL (1964b) Pathogenesis of polycystic kidneys. Survey of results of microdissection. Arch Pathol 77:510–512

    PubMed  CAS  Google Scholar 

  • Osathanondh V, Potter EL (1964c) Pathogenesis of polycystic kidneys. Type 1 due to hyperplasia of interstitial portions of collecting tubules. Arch Pathol 77:466–473

    PubMed  CAS  Google Scholar 

  • Pazour GJ (2004) Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease. J Am Soc Nephrol 15:2528–2536

    PubMed  Google Scholar 

  • Pazour GJ, Rosenbaum JL (2002) Intraflagellar transport and cilia-dependent diseases. Trends Cell Biol 12:551–555

    PubMed  CAS  Google Scholar 

  • Pazour GJ, Dickert BL, Vucica Y, Seeley ES, Rosenbaum JL, Witman GB, Cole DG (2000) Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J Cell Biol 151:709–718

    PubMed  CAS  Google Scholar 

  • Pazour GJ, San Agustin JT, Follit JA, Rosenbaum JL, Witman GB (2002) Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr Biol 12:R378–R380

    PubMed  CAS  Google Scholar 

  • Phillips CL, Miller KJ, Filson AJ, Nurnberger J, Clendenon JL, Cook GW, Dunn KW, Overbeek PA, Gattone VH 2nd, Bacallao RL (2004) Renal cysts of inv/inv mice resemble early infantile nephronophthisis. J Am Soc Nephrol 15:1744–1755

    PubMed  Google Scholar 

  • Praetorius HA, Spring KR (2001) Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol 184:71–79

    PubMed  CAS  Google Scholar 

  • Praetorius HA, Spring KR (2003a) Removal of the MDCK cell primary cilium abolishes flow sensing. J Membr Biol 191:69–76

    PubMed  CAS  Google Scholar 

  • Praetorius HA, Spring KR (2003b) The renal cell primary cilium functions as a flow sensor. Curr Opin Nephrol Hypertens 12:517–520

    PubMed  Google Scholar 

  • Praetorius HA, Spring KR (2005) A physiological view of the primary cilium. Annu Rev Physiol 67:515–529

    PubMed  CAS  Google Scholar 

  • Praetorius HA, Frokiaer J, Nielsen S, Spring KR (2003) Bending the primary cilium opens Ca2+-sensitive intermediate-conductance K+ channels in MDCK cells. J Membr Biol 191:193–200

    PubMed  CAS  Google Scholar 

  • Praetorius HA, Praetorius J, Nielsen S, Frokiaer J, Spring KR (2004) Beta1-integrins in the primary cilium of MDCK cells potentiate fibronectin-induced Ca2+ signaling. Am J Physiol Renal Physiol 287:F969–F978

    PubMed  CAS  Google Scholar 

  • Pugh JL, Sweeney WE Jr, Avner ED (1995) Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int 47:774–781

    PubMed  CAS  Google Scholar 

  • Richards WG, Sweeney WE, Yoder BK, Wilkinson JE, Woychik RP, Avner ED (1998) Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 101:935–939

    Article  PubMed  CAS  Google Scholar 

  • Rohatgi R, Greenberg A, Burrow CR, Wilson PD, Satlin LM (2003) Na transport in autosomal recessive polycystic kidney disease (ARPKD) cyst lining epithelial cells. J Am Soc Nephrol 14:827–836

    PubMed  CAS  Google Scholar 

  • Rohatgi R, Zavilowitz B, Vergara M, Woda C, Kim P, Satlin LM (2004) Cyst fluid composition in human autosomal recessive polycystic kidney disease. Pediatr Nephrol 20:552–553

    Google Scholar 

  • Rossetti S, Torra R, Coto E, Consugar M, Kubly V, Malaga S, Navarro M, El-Youssef M, Torres VE, Harris PC (2003) A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int 64:391–403

    PubMed  CAS  Google Scholar 

  • Roy S, Dillon MJ, Trompeter RS, Barratt TM (1997) Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors. Pediatr Nephrol 11:302–306

    PubMed  CAS  Google Scholar 

  • Sato Y, Harada K, Kizawa K, Sanzen T, Furubo S, Yasoshima M, Ozaki S, Ishibashi M, Nakanuma Y (2005) Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli’s disease. Am J Pathol 166:49–60

    PubMed  CAS  Google Scholar 

  • Sharp AM, Messiaen LM, Page G, Antignac C, Gubler MC, Onuchic LF, Somlo S, Germino GG, Guay-Woodford LM (2005) Comprehensive genomic analysis of PKHD1 mutations in ARPKD cohorts. J Med Genet 42:336–349

    PubMed  CAS  Google Scholar 

  • Sullivan LP, Grantham JJ (1996) Mechanisms of fluid secretion by polycystic epithelia. Kidney Int 49:1586–1591

    PubMed  CAS  Google Scholar 

  • Sullivan LP, Wallace DP, Grantham JJ (1998) Chloride and fluid secretion in polycystic kidney disease. J Am Soc Nephrol 9:903–916

    PubMed  CAS  Google Scholar 

  • Sun Z, Amsterdam A, Pazour GJ, Cole DG, Miller MS, Hopkins N (2004) A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131:4085–4093

    PubMed  CAS  Google Scholar 

  • Sweeney WE, Avner ED (1996) BPK cyst fluid contains EGF and TGF-a like peptides which are motogenic and phosphorylate apical EGFR. J Am Soc Nephrol 7:1606

    Google Scholar 

  • Sweeney WE Jr, Avner ED (1998) Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 275:F387–F394

    PubMed  CAS  Google Scholar 

  • Sweeney WE, Chen Y, Nakanishi K, Frost P, Avner ED (2000) Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 57:33–40

    PubMed  CAS  Google Scholar 

  • Sweeney WE Jr, Hamahira K, Sweeney J, Garcia-Gatrell M, Frost P, Avner ED (2003) Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Kidney Int 64:1310–1319

    PubMed  CAS  Google Scholar 

  • Torres VE (2004) Therapies to slow polycystic kidney disease. Nephron Exp Nephrol 98:e1–e7

    PubMed  CAS  Google Scholar 

  • Torres VE (2005) Vasopressin antagonists in polycystic kidney disease. Kidney Int 68:2405–2418

    PubMed  Google Scholar 

  • Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH (2004) Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 10:363–364

    Google Scholar 

  • Veizis IE, Cotton CU (2005) Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells. Am J Physiol Renal Physiol 288:F474–F482

    PubMed  CAS  Google Scholar 

  • Veizis EI, Carlin CR, Cotton CU (2004) Decreased amiloride-sensitive Na+ absorption in collecting duct principal cells isolated from BPK ARPKD mice. Am J Physiol Renal Physiol 286:F244–F254

    PubMed  CAS  Google Scholar 

  • Wallace DP, Christensen M, Reif G, Belibi F, Thrasher B, Herrell D, Grantham JJ (2002) Electrolyte and fluid secretion by cultured human inner medullary collecting duct cells. Am J Physiol Renal Physiol 283:F1337–F1350

    PubMed  CAS  Google Scholar 

  • Wang S, Luo Y, Wilson PD, Witman GB, Zhou J (2004) The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area. J Am Soc Nephrol 15:592–602

    PubMed  Google Scholar 

  • Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M, Milliner DS, Torres VE, Harris PC (2002) The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 30:259–269

    PubMed  Google Scholar 

  • Ward CJ, Yuan D, Masyuk TV, Wang X, Punyashthiti R, Whelan S, Bacallao R, Torra R, LaRusso NF, Torres VE, Harris PC (2003) Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum Mol Genet 12:2703–2710

    PubMed  CAS  Google Scholar 

  • Welling LW, Grantham JJ (1991) Cystic and developmental diseases of the kidney. In: Brenner BMR, Rector FC (eds) The kidney. Saunders, Philadelphia, pp 1657–1694

    Google Scholar 

  • Wilson PD (2004a) Polycystic kidney disease. N Engl J Med 350:151–164

    PubMed  CAS  Google Scholar 

  • Wilson PD (2004b) Polycystic kidney disease: new understanding in the pathogenesis. Int J Biochem Cell Biol 36:1868–1873

    PubMed  CAS  Google Scholar 

  • Witzgall R (2005) New developments in the field of cystic kidney diseases. Curr Mol Med 5:455–465

    PubMed  CAS  Google Scholar 

  • Xiong H, Chen Y, Yi Y, Tsuchiya K, Moeckel G, Cheung J, Liang D, Tham K, Xu X, Chen XZ, Pei Y, Zhao ZJ, Wu G (2002) A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease. Genomics 80:96–104

    PubMed  CAS  Google Scholar 

  • Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, Rome LA, Sullivan LP, Grantham JJ (2000) cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57:1460–1471

    PubMed  CAS  Google Scholar 

  • Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Pelling JC, Grantham JJ (2003) Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 63:1983–1994

    PubMed  CAS  Google Scholar 

  • Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet JP (2004) Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279:40419–40430

    PubMed  CAS  Google Scholar 

  • Yamaguchi T, Hempson SJ, Reif GA, Hedge AM, Wallace DP (2006) Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 17:178–187

    PubMed  CAS  Google Scholar 

  • Ye M, Grant M, Sharma M, Elzinga L, Swan S, Torres VE, Grantham JJ (1992) Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J Am Soc Nephrol 3:984–994

    PubMed  CAS  Google Scholar 

  • Yoder BK, Hou X, Guay-Woodford LM (2002) The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 13:2508–2516

    PubMed  CAS  Google Scholar 

  • Zerres K, Rudnik-Schoneborn S, Steinkamm C, Mucher G (1996) Autosomal recessive polycystic kidney disease. Nephrol Dial Transplant 11 (Suppl 6):29–33

    PubMed  CAS  Google Scholar 

  • Zerres K, Mücher G, Becker J, Steinkamm C, Rudnik-Schöneborn S, Heikkilä P, Rapola J, Salonen R, Germino GG, Onuchic L, Somlo S, Avner ED, Harman LA, Stockwin JM, Guay-Woodford LM (1998) Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 76:137–144

    PubMed  CAS  Google Scholar 

  • Zerres K, Senderek J, Rudnik-Schoneborn S, Eggermann T, Kunze J, Mononen T, Kaariainen H, Kirfel J, Moser M, Buettner R, Bergmann C (2004) New options for prenatal diagnosis in autosomal recessive polycystic kidney disease by mutation analysis of the PKHD1 gene. Clin Genet 66:53–57

    PubMed  CAS  Google Scholar 

  • Zhang BH, Guan KL (2000) Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J 19:5429–5439

    PubMed  CAS  Google Scholar 

  • Zhang MZ, Mai W, Li C, Cho SY, Hao C, Moeckel G, Zhao R, Kim I, Wang J, Xiong H, Wang H, Sato Y, Wu Y, Nakanuma Y, Lilova M, Pei Y, Harris RC, Li S, Coffey RJ, Sun L, Wu D, Chen XZ, Breyer MD, Zhao ZJ, McKanna JA, Wu G (2004) PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc Natl Acad Sci USA 101:2311–2316

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Research Institute, Children’s Hospital Health System of Wisconsin, Medical College of Wisconsin, Milwaukee, WI 53226, USA

    William E. Sweeney Jr & Ellis D. Avner

  2. Director, Children’s Research Institute, Children’s Hospital Health System of Wisconsin, Associate Dean for Research, Children’s Corporate Center, Medical College of Wisconsin, Suite C-730, Mailstop CCC C730, 999 North 92nd Street, Wauwatosa, WI 53226, USA

    Ellis D. Avner

Authors
  1. William E. Sweeney Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ellis D. Avner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ellis D. Avner.

Additional information

The authors are supported by the National Institutes of Health (grant no. 1-P50-DK57306), the PKD Foundation (grant no. 76a2r), and the Children’s Research Institute, Children’s Hospital of Wisconsin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sweeney, W.E., Avner, E.D. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res 326, 671–685 (2006). https://doi.org/10.1007/s00441-006-0226-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00441-006-0226-0

Keywords

Search

Navigation